Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Discover where to find high return investment opportunities that can enhance your portfolio. Take action to secure your financial future.
25,925 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
New to dividend investing? This beginner's guide breaks down how to start, pick safe dividend stocks, use DRIPs, and ...
A notable stake by Starboard Value in Fluor hints at renewed confidence in the industrial cycle. This article explain...
Ericsson's 2026 earnings trajectory hinges on 5G expansion, services, and software. This guide breaks down what to wa...
As 2026 unfolds, investors eye three key covered call ETFs for steady monthly income. This analysis compares ISPY, JE...
Are credit card cash rewards considered taxable income? Most personal rewards are not taxed, but there are important ...
A closer look at Janus Henderson's CLO ETFs shows a safety-first anchor in JAAA and a bolder, higher-yield challenger...
loanDepot is re-entering the wholesale market after a four-year pause, launching a new leadership team and a platform...
Choosing the right index fund in retirement matters more than most people realize. This guide breaks down SP500 vs to...
Oil jumps to $100 per barrel, sparking renewed interest in energy income strategies. This report breaks down XOMO, ML...
Investors are weighing whether UTES's AI-driven utility tilt justifies a roughly 0.50% fee as 2026 market conditions ...
Valero Energy posts a 98% capacity utilization for 2025, expands its dividend, and exits California, fueling a fresh ...